Press Releases

Press Releases concerning clinical trial results are intended to inform interested parties of the advancements of laser technology in process, not to imply new indications for use. Erchonia supports only those indications for use, cleared by the FDA via 510(k).

Erchonia Corporation First to Receive FDA Approval on Use of Laser During Liposuction

For Information Contact: 
Erchonia Corporation
2021 Commerce Drive
McKinney, TX  75071
ATT:  Charlie Shanks
VP, Sales and Marketing
214.733.5203
cshanks@erchonia.com 

Erchonia Announces New World Headquarters to Open in 2004

For Information Contact:
Charlie Shanks
VP Sales & Marketing
(480) 633-3129
cshanks@erchonia.com